BMP Sunstone Nominates George Bickerstaff for Election to Board of Directors

Business Wire,  April 7, 2008  

• E-mail
• Print
• Link

PLYMOUTH MEETING, Pa. -- BMP Sunstone Corporation (NASDAQ:BJGP) ("BMP Sunstone" or the "Company") today announced that it has nominated George Bickerstaff for election to its board of directors at the Company's annual meeting on April 28, 2008.

Mr. Bickerstaff has over two decades of experience in corporate finance, public company reporting, and management and strategic planning. He has held senior financial positions in publicly listed companies, including that of Chief Financial Officer of Novartis Pharma AG from 2000 until May 2005. Mr. Bickerstaff is currently a Managing Director at CRT Capital Group LLC. At CRT, he has played key roles in public offerings and domestic and international transactions, including with China-based, U.S. publicly listed companies. Mr. Bickerstaff started his career at General Electric in manufacturing and finance. He subsequently joined The Dun & Bradstreet Corporation where he held various senior finance positions, including Chief Financial Officer of IMS Health. Additionally, he serves on the boards of directors of Oracle Healthcare Acquisition Corporation (OTCBB: OHAQ) and Vion Pharmaceuticals (NASDAQ: VION). He is also on the board of directors and audit committee of the GAVI Alliance for Vaccines & Immunization Fund, headquartered in Geneva, Switzerland.

"George Bickerstaff is a proven leader with extensive experience guiding companies around the world through strategic transformation and growth. He has unparalleled experience in the fields of corporate finance and healthcare. We believe that, if elected, Mr. Bickerstaff's experience will be a great asset for BMP Sunstone," said David Gao, Chief Executive Officer of BMP Sunstone.

Other nominees to the board of directors include incumbent directors Martyn D. Greenacre, David Gao, Jack M. Ferraro, Frank J. Hollendoner, John W. Stakes III, M.D., Albert Yeung, Zhiqiang Han and Zhijun Tong.

Mr. Gao continued, "On behalf of BMP Sunstone, I would like to thank Mr. Michel de Beaumont for his dedicated service over the last four years. During this time, we have grown significantly from a small Beijing-based marketing & sales consulting company into a diversified service provider in China's exciting healthcare market. Michel's leadership and vision have been invaluable to BMP Sunstone, and we wish him all the best."

About BMP Sunstone Corporation

BMP Sunstone Corporation, through its subsidiaries, is a pharmaceutical marketing and distribution company that is building a proprietary portfolio of branded pharmaceutical and healthcare products in China and is pursuing partnerships with other companies seeking to enter the Chinese pharmaceutical market. It is the only U.S. public company to offer industry partners a comprehensive suite of market-entry services in China that includes pre-market entry analysis, clinical trial management, product registration, market research, as well as pharmaceutical marketing and distribution. The company provides distribution services for a wide range of products, including Western medicines, traditional Chinese medicines, bio-chemical medicines, medical applications, branded generic pharmaceuticals, over-the-counter healthcare products, and home healthcare supplies and equipments. BMP Sunstone's proprietary portfolio, primarily focusing on women's health and pediatrics. The Company is headquartered in Plymouth Meeting, Pennsylvania.

Safe Harbor Statement

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding the pending election to the Company's board of directors and the potential benefits the Company may derive from such election. These statements are subject to uncertainties and risks including the risks contained in reports filed by the Company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

COPYRIGHT 2008 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning